Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
919.98
+0.44 (0.05%)
At close: Apr 28, 2026
-11.54%
Market Cap 90.07B
Revenue (ttm) 75.76B
Net Income (ttm) 8.31B
Shares Out 97.90M
EPS (ttm) 84.85
PE Ratio 10.84
Forward PE 7.74
Dividend 40.00 (4.35%)
Ex-Dividend Date Apr 22, 2026
Volume 9,871
Average Volume 53,283
Open 924.96
Previous Close 919.54
Day's Range 918.00 - 930.00
52-Week Range 790.00 - 1,304.00
Beta 0.22
RSI 42.99
Earnings Date Apr 27, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1888
Employees 1,380
Stock Exchange Pakistan Stock Exchange
Ticker Symbol ABOT
Full Company Profile

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.

Financial Statements

News

There is no news available yet.